Adalimumab
Adalimumab was ranked 1620th of 1,796 medicines by items in May 2026, with 3 items, up 200.0% on a year earlier.
Dispensed in May 2026
Rolling 12 months
Net ingredient cost · May 2026
Figure 1. Adalimumab: national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to May 2026
Embed this chart
Free to reuse with the credit line above.
At a glance
- Therapeutic class Drugs used in rheumatic diseases and gout
- Presentations 3 shown
- Average cost / item £680.80
- Year on year Up 200.0% on a year earlier
Top presentations, May 2026
The individual products dispensed under Adalimumab this month.
| Presentation | BNF code | Items | Net ingredient cost |
|---|---|---|---|
| Humira 40mg/0.4ml solution for injection pre-filled pens | 1001030S0BBADAD | 1 | £704 |
| Imraldi 40mg/0.8ml solution for injection pre-filled pens | 1001030S0BFAAAB | 1 | £634 |
| Yuflyma 40mg/0.4ml inj pre-filled syringes | 1001030S0BHABAE | 1 | £704 |
Source: NHSBSA Prescription Cost Analysis · to May 2026 OGL v3.0
Where Adalimumab is dispensed
The regions and dispensing practices with the highest Adalimumab volumes.
Top regions
Top dispensing practices
Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.
In NHS hospitals
Adalimumab is also used in NHS secondary care. See the indicative hospital cost, monthly trend and the trusts using it most on the hospital medicines page.
Compare Adalimumab with
Other medicines in the same BNF section, by prescribing volume.
Download this data
The monthly series for Adalimumab is in this page's CSV. For the ranked national series across every medicine, with the method and caveats documented, see the most-prescribed medicines dataset in our open data catalogue.